Noise-induced hearing loss

Sudden Hearing Loss: AudioCure's Novel Compound AC102 Restores Hearing in Preclinical Models, Published in PNAS

Retrieved on: 
Monday, April 1, 2024
General Health, Health, Science, Pharmaceutical, Research, Speech, Radical, Regeneration, Hearing loss, Patient, PNAS, Noise-induced hearing loss, Hope, Death, Neuron, Huber loss, Safety, CSO, Multimedia, Pharmaceutical industry

A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models.

Key Points: 
  • A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models.
  • Sudden hearing loss is often treated with anti-inflammatory corticosteroids without regulatory approval or reliable evidence of effectiveness.
  • A single middle ear application of AC102 after noise trauma restores hearing to near pre-trauma levels after 14 days.
  • Dr. Reimar Schlingensiepen, CEO of AudioCure Pharma, explains, "The HODOKORT study highlights the treatment gap for sudden hearing loss.

Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings

Retrieved on: 
Wednesday, January 31, 2024
Hearing, SAN, Best Buy, Noise-induced hearing loss, Personal, FDA, Target, Ageing, OTC, MSRP, LINK, BCBS, Health, Insurance, Bluetooth, Hearing loss, Video game

SAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024).

Key Points: 
  • SAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024).
  • The new devices expand the brand’s portfolio of offerings with a new earbud form factor and a completely-in-canal option focused on Eargo signature essentials.
  • For over a decade, Eargo has set the industry standard for pairing award-winning discreet and effortless hearing devices with ongoing expert support.
  • Eargo’s portfolio of offerings proves that people with hearing loss don’t need to compromise on quality or a trusted experience when seeking the support they need.

Lucid Hearing Launches Tala™ Hearing Aid - Sleek, Discreet Design Offers Wireless Streaming and Patented LucidShape® App Control

Retrieved on: 
Tuesday, August 29, 2023
Schnell, Music, Communication, University, Moses Austin, Prevalence, Noise, Hearing loss, Speech, EVP, PDL, Innovation, VP/MS, Research, UTD, Deafness, Food and Drug Administration, Noise-induced hearing loss, Best Buy, Audiology, Hearing, Algorithm, OTC, Kool-Aid, Fortification, R, FDA, National Institute on Deafness and Other Communication Disorders, Food, Communes of Burundi, Personal protective equipment

FORT WORTH, Texas , Aug. 29, 2023 /PRNewswire/ -- Lucid Hearing, LLC announced today the release of its latest hearing aid – Tala™, noting that the product is the highest premium option in the company's OTC product line. The Fort Worth-based market leader and global provider of advanced hearing technology and audio solutions said Tala initially will be sold on lucidhearing.com and at Best Buy, with multiple retailers, being added to distribution in the coming months. Tala's price will be $1,299, and future products with the company's new proprietary Precision Directional Listening System (PDL) will be added to the line to address the full spectrum of hearing loss – whether mild to moderate, or more severe.

Key Points: 
  • "Tala is innovative, discreet and powerful and uses our most advanced technology released to date," said Steve Iseberg, VP of Innovation for Lucid Hearing.
  • "This product's discreet design will make it popular among individuals who have mild to moderate hearing loss, and who want a solution that doesn't look like a hearing aid.
  • Additionally, like all of Lucid Hearing's premium OTC products, Tala can be upgraded to a custom programmed prescription hearing aid solution.
  • This is something that is unique to Lucid Hearing and our continuum of OTC and prescription hearing aid products," Griffin explained.

Tuned Launches Innovative Pediatric Hearing Care Program

Retrieved on: 
Tuesday, June 27, 2023
Learning, Insurance, Communication, University, Pediatrics, Language development, IPad, Noise, Hearing loss, Speech, Parent, University of California, San Francisco, ADHD, Brain, Tuning fork, Language, School, Noise-induced hearing loss, Patient, Risk, Hearing, Reading, Entrepreneurship, Ageing, Research, Behavior, Dentistry, Nursing

Offered as an employer-sponsored benefit, Tuned's innovative pediatric program combines modern hearing knowledge and technology with teleaudiology to modernize a testing method that has not changed for almost 50 years.

Key Points: 
  • Offered as an employer-sponsored benefit, Tuned's innovative pediatric program combines modern hearing knowledge and technology with teleaudiology to modernize a testing method that has not changed for almost 50 years.
  • Children with hearing loss are often overlooked, leaving them to languish in schools, undiagnosed and untreated, at risk for developmental delays .
  • "Hearing loss has always been ignored because it can't be seen, and most people don't understand the connection between hearing and learning.
  • The program includes care navigation, which helps parents navigate potential treatments or solutions, which include understanding what local assistance is available.

July 4th Fireworks Safety: Experts Share Simple Tips for Hearing Protection

Retrieved on: 
Tuesday, June 27, 2023
Database, Hobby, DBP, Noise, American Speech–Language–Hearing Association, Hearing loss, NIHL, Doctor of Philosophy, Fireworks, Pain, ASHA, Noise-induced hearing loss, Risk, Hearing, World Health Organization, Nursing

ROCKVILLE, Md., June 27, 2023 /PRNewswire/ -- The booms, pops, and crackles of fireworks and firecrackers are signature sounds of the July 4th holiday, but according to the American Speech-Language-Hearing Association (ASHA), they could come at the high cost of irreversible hearing loss if people don't take simple steps to protect themselves.

Key Points: 
  • Fireworks could come at the high cost of hearing loss if people don't take simple steps to protect themselves.
  • It just means we need to take steps to minimize our risk, and luckily, it's not that difficult to do so."
  • Any exposure to excessively loud noise can cause a form of hearing loss called noise-induced hearing loss (NIHL).
  • However, a single loud blast or explosion that lasts for less than 1 second can cause permanent hearing loss right away.

ASHA Offers Tips for Ear Care and Hearing Protection This Summer

Retrieved on: 
Tuesday, May 30, 2023
Infection, Pressure, Hobby, Ear, Noise, American Speech–Language–Hearing Association, Hearing loss, Doctor of Philosophy, Pain, Ear canal, ASHA, Swimming, Noise-induced hearing loss, Huber loss, Hearing, Environment, ATV, News, Skin, Safety, Dentistry, Jewellery, Personal protective equipment, Petroleum jelly, Toy

ROCKVILLE, Md., May 30, 2023 /PRNewswire/ -- With summer fast approaching, the American Speech-Language-Hearing Association (ASHA) is calling attention to a lesser-known hazard of many popular seasonal activities: ear and hearing damage. The good news, according to ASHA, is that by taking some simple steps, people of all ages can protect their ears from both temporary and lasting problems.

Key Points: 
  • "Most of us take our hearing and ear health for granted until we start to have problems.
  • ASHA encourages people to help prevent hearing loss by taking these steps:
    Use Hearing Protection: Basic earplugs, which are available at drug stores, offer surprisingly good protection for most adults.
  • Stay Away From Noise Sources: From a hearing protection perspective, the worst place someone can position themselves is near speakers, a stage, or another type of noise emitter.
  • Swimmer's ear is an infection of the outer ear canal caused by moisture trapped in the ear canal or an injury to the ear canal.

Hearing Loss Association of America (HLAA) Announces 2023 Hear for Life Corporate Partners

Retrieved on: 
Monday, April 24, 2023
Hearing loss, Heart, Life, Communication, Noise-induced hearing loss, Risk, Telecommunications relay service, Dentistry, Personal protective equipment, Hearing

ROCKVILLE, Md., April 24, 2023 /PRNewswire/ -- The Hearing Loss Association of America (HLAA) announces its Hear for Life corporate partners for 2023. For the second year, CapTel and Starkey lead a group of companies joining HLAA's vital mission to promote hearing health, and to support and empower the increasing number of people with, and at risk of, hearing loss. These companies team with HLAA throughout the year to educate the public and support initiatives that improve the lives of people with hearing loss.

Key Points: 
  • Companies join HLAA's mission to educate, empower and support
    ROCKVILLE, Md., April 24, 2023 /PRNewswire/ -- The Hearing Loss Association of America (HLAA) announces its Hear for Life corporate partners for 2023.
  • Hear for Life partners team with HLAA to promote hearing health and improve the lives of people with hearing loss.
  • Hearing loss is a growing public health crisis that affects 48 million Americans, including young people who are at increasing risk for noise-induced hearing loss.
  • HLAA 2023 Hear for Life partners include:
    For more information and to learn how to become a HLAA Hear for Life partner, visit: hearingloss.org/hearforlife , or contact Marilyn DiGiacobbe at [email protected] .

Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss

Retrieved on: 
Thursday, December 15, 2022
Health, General Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Fast Track, Therapy, Security (finance), Secondary research, Speech, Frequency, Mass General Brigham, Regenerative medicine, Ageing, Intellectual property, Scripps Research, Cochlea, Noise-induced hearing loss, PCA, Trial of the century, Sound, Science, Patient, Research, MS, Sensorineural hearing loss, Degenerative disease, SNHL, FDA, Hearing loss, COVID-19, Cell, Ear, Breakthrough therapy, Growth, GSK3, Failure, Safety, Massachusetts Eye and Ear, Brain, Hearing, Marketing, Health, Speech perception, Legislation, Massachusetts Institute of Technology, Pharmaceutical industry

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a persons innate potential to restore function, today announced that it has dosed a first patient in the Phase 1b study of FX-345, the Companys second hearing restoration candidate for sensorineural hearing loss (SNHL).

Key Points: 
  • Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a persons innate potential to restore function, today announced that it has dosed a first patient in the Phase 1b study of FX-345, the Companys second hearing restoration candidate for sensorineural hearing loss (SNHL).
  • Advancing FX-345 to the clinic is an exciting milestone as we further our pioneering work to develop regenerative therapeutics for hearing loss.
  • Frequency is also evaluating FX-322, a therapeutic candidate for SNHL, in an ongoing Phase 2b study (FX-322-208).
  • Sensorineural hearing loss is the most common form of hearing loss, typically resulting from damage to sensory hair cells in the cochlea.

'Tis the Season to Protect Your Hearing

Retrieved on: 
Tuesday, December 13, 2022
Parent, ASHA, Imagination, Noise-induced hearing loss, Noise, Child, Hearing, Electronics, Eating, Hearing loss, American Speech–Language–Hearing Association, Caregiver, Risk, Toy, Personal protective equipment, Dentistry, Cassette tape, Satellite navigation device

ROCKVILLE, Md., Dec. 13, 2022 /PRNewswire/ -- The year-end season of cheer is also a time for excessive noise—from loud holiday gatherings to toys and technology gifts that can reach potentially dangerous sound levels.

Key Points: 
  • Hearing loss due to noise exposure (called noise-induced hearing loss) is completely preventable.
  • Below are three common sources of excessively loud noise, along with tips for hearing protection.
  • Blocks, puppets, chunky puzzles, and board books are just some items that let children build their imagination as well as protect their hearing.
  • ASHA recommends that everyone learn the signs of hearing loss and seek out a hearing evaluation from a certified audiologist if they ever have concerns about their hearing or pain/ringing in their ears.

Frequency Therapeutics to Host Virtual Investor Event, Highlighting Hearing Restoration Candidate FX-322 in Advance of Q1 Clinical Results

Retrieved on: 
Thursday, November 17, 2022
Health, Science, Pharmaceutical, Research, Clinical Trials, SVP, Marketing, PCA, Hearing loss, Communication studies, Sensorineural hearing loss, Breakthrough therapy, Scripps Research, Security (finance), Medical College of Wisconsin, Massachusetts Institute of Technology, Growth, EST, SNHL, MD, Webcast, Q&A, Ageing, Science, Research, Bias, Doctor of Philosophy, Saint Louis University, Intellectual property, Otorhinolaryngology, COVID-19, Mass General Brigham, Legislation, Health, Degenerative disease, Cochlea, FDA, Fast Track, Failure, Frequency, Therapy, Massachusetts Eye and Ear, Ear, Secondary research, Speech perception, Noise-induced hearing loss, SSM Health, Medicine, Otology, Regenerative medicine, SSM, Regeneration, Patient, Pharmaceutical industry, Management

A Phase 2b study of FX-322 (FX-322-208) is fully enrolled with clinical results anticipated in the first quarter of 2023.

Key Points: 
  • A Phase 2b study of FX-322 (FX-322-208) is fully enrolled with clinical results anticipated in the first quarter of 2023.
  • They will also discuss how a medicine for cochlear regeneration may fit with currently available hearing devices and the clinical significance of speech perception on overall hearing.
  • Kevin Franck, Ph.D., SVP, Strategic Marketing and New Product Planning: Cochlear restoration market development and the demand for new therapeutics.
  • Carl LeBel, Ph.D., Chief Development Officer: FX-322 hearing restoration program and the clinical development path.